2m 2m 2m 2m 2m 2m 2m
Bio Green Med (BGMS)
NASDAQ
$0.67+$0.004 (+0.53%)
Price as of Jun 23, 2026 7:52 PM EDT- $3.8MMarket Cap
- N/A1-Year Change
- BiotechnologyIndustry
Bio Green Med (BGMS)
$0.67+$0.004 (+0.53%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 0 -100.00% | 43,000 -89.76% | 420,000 N/A | 0 N/A | |
Cost of Revenue | 609,000 N/A | N/A N/A | N/A N/A | N/A N/A | |
Gross Profit | -609,000 -1,516.28% | 43,000 -89.76% | 420,000 N/A | 0 N/A | |
Sales and Marketing Expense | 7.7M +43.12% | 5.4M -19.74% | 6.7M -8.99% | 7.4M -1.06% | |
Research and Development Expense | -848,000 -87.26% | -6.7M -65.26% | -19.2M -5.52% | -20.3M +30.99% | |
Depreciation and Amortization Expense | 5,000 -16.67% | 6,000 -80.65% | 31,000 -3.12% | 32,000 -25.58% | |
Total Operating Expenses | 9.2M -23.85% | 12.0M -53.44% | 25.9M -6.45% | 27.7M +20.57% | |
Operating Profit | -8.4M -29.80% | -12.0M -46.88% | -22.6M +6.61% | -21.2M +12.24% | |
Interest Income | N/A N/A | 12,000 -95.49% | 266,000 +26.67% | 210,000 +1,212.50% | |
Interest Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Interest Income and Expense and Net | 0 -100.00% | 12,000 -95.49% | 266,000 +26.67% | 210,000 +1,212.50% | |
Total Nonoperating Income and Expense | 5.4M +54,260.00% | 10,000 +110.20% | -98,000 -105.63% | 1.7M +753.43% | |
Income before Taxes | -3.0M -75.06% | -12.0M -46.93% | -22.6M +6.61% | -21.2M +12.24% | |
Income Taxes | 7,000 +100.90% | -782,000 -73.90% | -3.0M -36.49% | -4.7M +22.62% | |
Extraordinary Items | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Net Income | -3.0M -72.92% | -11.2M -50.46% | -22.6M +6.61% | -21.2M +12.24% | |
Net Income from Continuing Operations Applicable to Common | -14.1M +25.69% | -11.2M -50.39% | -22.6M +6.61% | -21.2M +12.24% | |
Basic EPS and Net Income | -6.45 -98.72% | -504.30 +1,785.23% | -26.75 +1,179.90% | -2.09 -2.34% | |
Diluted EPS and Net Income | -6.45 -98.72% | -504.30 +1,751.32% | -27.24 +1,203.35% | -2.09 -2.34% | |
Basic Weighted Average Shares | 2.2M -90.21% | 22.3M +2,522.66% | 850,815 -91.37% | 9.9M +10.51% | |
Diluted Weighted Average Shares | 2.2M -90.21% | 22.3M +2,522.66% | 850,815 -91.37% | 9.9M +10.51% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 3.5M +11.73% | 3.1M -7.13% | 3.4M -81.54% | 18.3M -49.94% | |
Short-Term Investments | N/A N/A | N/A N/A | N/A N/A | 4.5M +1.56% | |
Cash and Cash Equivalents and Short-Term Investments | 3.5M +11.73% | 3.1M -7.13% | 3.4M -85.21% | 22.8M -44.32% | |
Total Current Assets | 6.3M +70.28% | 3.7M -50.64% | 7.4M -69.51% | 24.4M -40.38% | |
Accumulated Depreciation | 284,000 -33.02% | 424,000 +0.95% | 420,000 +9.66% | 383,000 +6.09% | |
Property and Plant and Equipment and Net | N/A N/A | 3,000 -66.67% | 9,000 -71.87% | 32,000 -50.00% | |
Total Long-Term Assets | 200,000 +6,566.67% | 3,000 -66.67% | 9,000 -71.87% | 32,000 -50.00% | |
Total Assets | 8.2M +99.93% | 4.1M -53.50% | 8.8M -68.61% | 28.1M -34.13% | |
Income Taxes Payable | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Short-Term Debt | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Current Liabilities | 1.3M -78.75% | 6.3M -23.20% | 8.2M +8.65% | 7.5M +41.88% | |
Total Long-Term Debt | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Long-Term Liabilities | 2,000 -60.00% | 5,000 -86.49% | 37,000 -65.09% | 106,000 +253.33% | |
Total Liabilities | 1.3M -78.57% | 6.3M -23.54% | 8.2M +7.63% | 7.6M +43.07% | |
Retained Earnings | -454.4M +3.39% | -439.5M +2.62% | -428.3M +5.56% | -405.7M +5.39% | |
Total Stockholders Equity | N/A N/A | -2.2M -458.15% | 607,000 -96.19% | 15.9M -57.23% | |
Total Shares Outstanding | 5.4M +14,529.86% | 36,913 -96.51% | 1.1M -88.76% | 9.4M -5.71% | |
Cash Flow | |||||
Cash from Operating Activities | -4.8M -40.30% | -8.0M -50.41% | -16.1M -22.64% | -20.8M +12.34% | |
Capital Expenditures | N/A N/A | 6,000 0.00% | 6,000 -14.29% | 7,000 -74.07% | |
Cash from Investing Activities | N/A N/A | -6,000 0.00% | -6,000 -14.29% | -7,000 -74.07% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | 5.3M -32.70% | 7.8M +822.41% | 848,000 -71.71% | 3.0M -86.21% | |
Financials Ratio | |||||
Gross Margin | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Operating Margin | N/A N/A | -27,916.28% +418.80% | -5,380.95% N/A | N/A N/A | |
Return on Assets | -49.39% -71.55% | -173.58% +41.53% | -122.64% +104.34% | -60.02% +26.14% | |
Return on Equity | N/A N/A | 1,428.84% +623.05% | -273.18% +242.81% | -79.69% +48.77% | |
Revenue Growth | -100.00% +11.41% | -89.76% N/A | N/A N/A | N/A N/A | |
Current Ratio | 4.70 +701.21% | 0.59 -35.73% | 0.91 -71.94% | 3.25 -57.98% | |
Cash Ratio | 2.63 +425.75% | 0.50 +20.92% | 0.41 -83.01% | 2.44 -64.72% | |
Debt-to-Equity Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Debt-to-Assets Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow